• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  (1R,2R)-1,2-cyclohexane-diaminepyrophosphato-platinum(II)
Trade Name:  N/A
Date Designated:  10/25/2018
Orphan Designation:  Treatment of thymoma and thymic carcinoma
Orphan Designation Status:  Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
Marketing Approval Date:  N/A
Approved Labeled Indication:  
Exclusivity End Date:    N/A
Phosplatin Therapeutics LLC
1350 6th Avenue
3rd Floor
New York, New York 10019

The sponsor address listed is the last reported by the sponsor to OOPD.